Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Feasibility of hepatic artery administration of docetaxel evaluated
August 18th, 2005
Researchers investigated the feasibility of administering docetaxel via the hepatic artery in advanced breast cancer patients. "Taxanes are largely metabolized and almost exclusively excreted in the feces by the liver through the biliary pathway, thus providing a rationale for investigating the activity of their hepatic artery delivery in case of liver metastases. The aim of this study was to assess the feasibility of administering docetaxel via the hepatic artery in advanced breast cancer patients in whom the liver was the only or the predominant site of metastatic involvement," scientists writing in the journal Tumori reported. "The dose was...
Source: Women's Health Weekly (2005-08-18)
|
